Tunicamycin, a new antibiotic. 3. Reversal of the antiviral activity of tunicamycin by aminosugars and their derivatives.
D000606:Amino Sugars / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000037:antagonists & inhibitors*; D000998:Antiviral Agents / Q000037:antagonists & inhibitors*; D002460:Cell Line; D002642:Chick Embryo; D002784:Cholesterol / Q000494:pharmacology; D046508:Culture Techniques; D005944:Glucosamine / Q000494:pharmacology; D006386:Hemagglutination Tests; D006595:Hexosamines / Q000494:pharmacology; D006601:Hexoses / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D009522:Newcastle disease virus / Q000187:drug effects / Q000254:growth & development; D010429:Pentoses / Q000494:pharmacology; D014776:Virus Cultivation
D000606:Amino Sugars; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D006595:Hexosamines; D006601:Hexoses; D010429:Pentoses; D002784:Cholesterol; D008274:Magnesium; D005944:Glucosamine